Co-Authors
This is a "connection" page, showing publications co-authored by THOMAS KOSTEN and SHAWN HIRSCH.
Connection Strength
0.575
-
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2024 Aug 16.
Score: 0.244
-
Comorbid alcohol use disorder and posttraumatic stress disorder: A proof-of-concept randomized placebo-controlled trial of buprenorphine and naltrexone combination treatment. Alcohol Clin Exp Res (Hoboken). 2023 Sep; 47(9):1756-1772.
Score: 0.228
-
FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder. Neuropsychopharmacology. 2023 07; 48(8):1144-1154.
Score: 0.054
-
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
Score: 0.049